Lasa Supergenerics Limited (NSE:LASA)
India
· Delayed Price · Currency is INR 11.96
+0.23 (1.96%)
Jul 4, 2025, 3:14 PM IST
Lasa Supergenerics Revenue
In the fiscal year ending March 31, 2025, Lasa Supergenerics had annual revenue of 1.47B INR with 41.23% growth. Lasa Supergenerics had revenue of 391.38M in the quarter ending March 31, 2025, with 70.97% growth.
Revenue
1.47B
Revenue Growth
+41.23%
P/S Ratio
0.41
Revenue / Employee
19.15M
Employees
77
Market Cap
599.21M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 525.78B |
| Divi's Laboratories | 93.60B |
| Cipla | 272.67B |
| Apollo Hospitals Enterprise | 217.94B |
| Zydus Lifesciences | 232.42B |
| Mankind Pharma | 122.07B |
| Aurobindo Pharma | 317.24B |
| Fortis Healthcare | 77.83B |